Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
VSTS
3 Unpopular Stocks We Steer Clear Of StockStory - Tue Dec 30, 2025

3 Unpopular Stocks We Steer Clear Of

FTRE : 16.81 (-2.55%)
VSTS : 6.58 (-1.35%)
EXAS : 101.74 (+0.18%)
Quest Diagnostics, Inc_ logo on building-by Tada Images via Shutterstock
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? Barchart - Mon Dec 15, 2025

Quest Diagnostics has outperformed the broader healthcare sector over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.

XLV : 155.51 (+0.46%)
DGX : 173.79 (+0.15%)
EXAS : 101.74 (+0.18%)
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS Business Wire - Thu Dec 11, 2025

New data reveals Oncodetect’s powerful prognostic performance in one of the largest TNBC MRD studies to date 1

EXAS : 101.74 (+0.18%)
EXAS
1 Healthcare Stock for Long-Term Investors and 2 We Avoid StockStory - Wed Dec 10, 2025

1 Healthcare Stock for Long-Term Investors and 2 We Avoid

EXAS : 101.74 (+0.18%)
ALHC : 20.22 (+2.38%)
ALGN : 156.03 (-0.08%)
MOV
3 Overrated Stocks That Concern Us StockStory - Wed Dec 3, 2025

3 Overrated Stocks That Concern Us

MOV : 21.01 (+1.89%)
EXAS : 101.74 (+0.18%)
NEO : 11.76 (unch)
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights PR Newswire - Fri Nov 28, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

SEMR : 11.89 (unch)
MRSN : 29.04 (+0.38%)
EXAS : 101.74 (+0.18%)
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN PR Newswire - Thu Nov 27, 2025

NEW YORK , Nov. 27, 2025 / PRNewswire/ --

SEE : 41.52 (+0.22%)
MRSN : 29.04 (+0.38%)
EXAS : 101.74 (+0.18%)
CDTX : 221.03 (+0.06%)
Halper Sadeh LLC Encourages GDOT, BLFY, EXAS Shareholders to Contact the Firm to Discuss Their Rights PR Newswire - Tue Nov 25, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

BLFY : 12.51 (+0.64%)
GDOT : 12.60 (-1.64%)
EXAS : 101.74 (+0.18%)
Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium Business Wire - Mon Nov 24, 2025

First clinical validation of the Oncodetect ® test to be presented in triple negative breast cancer; signals highly sensitive molecular residual disease (MRD) detection ...

EXAS : 101.74 (+0.18%)
EXAS
Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks StockStory - Sun Nov 23, 2025

Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks

EXAS : 101.74 (+0.18%)

Barchart Exclusives

3 Best Dividend Aristocrats to Buy in 2026 Barchart - Fri Jan 2, 6:00PM CST
These Dividend Aristocrats have strong earnings growth, solid yields, and Wall Street buy ratings stand out as smart income plays for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot